IDCRP is committed to reducing the impact of infectious diseases in the military population through collaborative clinical research
Learn More >>

IDCRP at IDWeek October 3-7, 2018 | San Francisco, CA

IDCRP researchers presented over 25 posters and an oral presentation on acute respiratory infections, deployment and travel related infections, Human Immunodeficiency Virus, sexually transmitted infections, skin and soft tissue infections and trauma related infections at IDWeek from October 3 to 7 in San Francisco, CA.

NovaDigm Therapeutics Awarded $6 Million to Conduct a Phase 2a Staphylococcus aureus Vaccine Trial 

NovaDigm will collaborate with the Uniformed Services University of the Health Sciences (USU) on the execution of the Phase 2a study among U.S. Army Infantry trainees at Fort Benning, GA.